2025 annual financial data
Neumora Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -241,156,000 USD and net income was -236,928,000 USD.
Operating cash flow was -206,440,000 USD.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -241,156,000 USD
- Net income
- -236,928,000 USD
- Operating cash flow
- -206,440,000 USD